Skip to main content

Dental Implant

0
Pipeline Programs
3
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Melodia Therapeutics
Melodia TherapeuticsSwitzerland - Basel
5 programs
Immediately implant placementN/A1 trial
Implant placementN/A1 trial
Implant placement TS IIIN/A1 trial
Implant placement with 3.5 mm diameter KS implants.N/A1 trial
Implant placement with soi surface in diabetic subjectsN/A1 trial
Active Trials
NCT06286579Not Yet Recruiting70Est. Jan 2028
NCT05847907Not Yet Recruiting50Est. Jan 2028
NCT05843981Not Yet Recruiting42Est. Jan 2028
+2 more trials
Align Technology
2 programs
Dental Implant Crown TreatmentN/A
Treatment of implant single crownN/A1 trial
Active Trials
NCT05165563Completed40Est. Oct 2021
Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
Standard implantN/A1 trial
Active Trials
NCT03225495Unknown40Est. Jul 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Melodia TherapeuticsImmediately implant placement
Melodia TherapeuticsImplant placement with soi surface in diabetic subjects
Melodia TherapeuticsImplant placement with 3.5 mm diameter KS implants.
Melodia TherapeuticsImplant placement TS III
Melodia TherapeuticsImplant placement
Align TechnologyTreatment of implant single crown
Geistlich PharmaStandard implant

Clinical Trials (7)

Total enrollment: 374 patients across 7 trials

NCT06286579Melodia TherapeuticsImmediately implant placement

SOI Immediately vs Delayed

Start: Mar 2024Est. completion: Jan 202870 patients
N/ANot Yet Recruiting
NCT06286566Melodia TherapeuticsImplant placement with soi surface in diabetic subjects

Soi TS3 Surface in Patients With and Without Type 2 Diabetes

Start: Mar 2024Est. completion: Jan 202884 patients
N/ANot Yet Recruiting
NCT06276712Melodia TherapeuticsImplant placement with 3.5 mm diameter KS implants.

RCT Comparing KS Versus TS for Ovedenture

Start: Mar 2024Est. completion: Jan 202848 patients
N/ANot Yet Recruiting
NCT05843981Melodia TherapeuticsImplant placement TS III

Comparison KS Versus TS

Start: Mar 2024Est. completion: Jan 202842 patients
N/ANot Yet Recruiting
NCT05847907Melodia TherapeuticsImplant placement

RCT KS-SA Versur KS-BA in Diabetic Patients

Start: Apr 2023Est. completion: Jan 202850 patients
N/ANot Yet Recruiting
NCT05165563Align TechnologyTreatment of implant single crown

Treatment Time Comparing Digital & Conventional Workflows

Start: Jul 2020Est. completion: Oct 202140 patients
N/ACompleted
NCT03225495Geistlich PharmaStandard implant

Comparison Between Ultra-narrow Diameter Implants (2,75 mm) Without Bone Regeneration Versus Standard Diameter Implants (4,3 mm) in Combination With Bone Regeneration

Start: Jul 2017Est. completion: Jul 201940 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.